Skip to main content
Log in

Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Polycystic ovarian syndrome is one of the most frequent endocrine dysfunctions in women in their fertile age. To date, a clear definition of the disease remains controversial among experts, partly because study results concerning diagnostics and therapy are incoherent. In this survey, we intend to give an insight into the diagnostics and treatment regimes of PCOS in Germany and subsequently compare these results to the current recommendations found in international literature.

Design

In 2005, 7,000 outpatient gynecologists received a questionnaire with questions on PCOS definition, diagnostics and treatment.

Results

The survey shows that it remains difficult for gynecologists to restrict themselves to the few definition criteria defined in the 2003 Rotterdam PCOS Consensus Workshop. Nevertheless, therapy and diagnosis of PCOS show a uniform treatment pattern. The current recommendations found in international literature have been widely implemented into clinical practice. Modern therapeutic approaches such as the use of metformin are increasingly acknowledged.

Conclusion

Further studies dealing with the diagnosis and therapy of PCOS will be necessary in order to establish guidelines, especially when looking at patients without a desire for reproduction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853–861

    Article  PubMed  CAS  Google Scholar 

  2. Hart R, Hickey M, Franks S (2004) Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:671–683

    Article  PubMed  Google Scholar 

  3. Matalliotakis I, Kourtis A, Koukoura O, Panidis D (2006) Polycystic ovary syndrome: etiology and pathogenesis. Arch Gynecol Obstet 274:187–197

    Article  PubMed  CAS  Google Scholar 

  4. ESHRE Rotterdam/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47

    Article  Google Scholar 

  5. Laven JSEM, Imani B, Eijkemans MJC, Fauser BCJM (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57:755–767

    Article  PubMed  Google Scholar 

  6. Fraser IS, Kovacs G (2004) Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:813–823

    PubMed  Google Scholar 

  7. Lakhani K, Seifalian AM, Atiomo WU, Hardiman P (2002) Polycystic ovaries. Br J Radiol 75:9–16

    PubMed  CAS  Google Scholar 

  8. Taylor AE, McCourt B, Martin KA et al (1997) Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248–2256

    Article  PubMed  CAS  Google Scholar 

  9. Pasquali R, Antenucci D, Casimirri F et al (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68:173–179

    Article  PubMed  CAS  Google Scholar 

  10. Kiddy DS, Hamilton-Fairley D, Bush A et al (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105–111

    Article  CAS  Google Scholar 

  11. Kirchengast S, Huber J (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255–1260

    Article  PubMed  CAS  Google Scholar 

  12. Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191

    Google Scholar 

  13. Silfen ME, Denburg MR, Manibo AM et al (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682–4688

    Article  PubMed  CAS  Google Scholar 

  14. Moran L, Norman RJ (2004) Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:719–736

    Article  PubMed  CAS  Google Scholar 

  15. Talbott E, Guzick D, Clerici A et al (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821–826

    Article  PubMed  CAS  Google Scholar 

  16. Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165–169

    Article  PubMed  CAS  Google Scholar 

  17. Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L (2002) Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care 25:1217–1222

    Article  PubMed  CAS  Google Scholar 

  18. Sowers JR (2003) Obesity as a cardiovascular risk factor. Am J Med 115(Suppl 8A):37S–41S

    Article  PubMed  CAS  Google Scholar 

  19. Elsenbruch S, Hahn S, Kowalsky D et al (2003) Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:5801–5807

    Article  PubMed  CAS  Google Scholar 

  20. Cattrall FR, Healy DL (2004) Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:803–812

    Article  PubMed  Google Scholar 

  21. Legro RS (2003) Diagnostic criteria in polycystic ovary syndrome. Semin Reprod Med 21:267–275

    Article  PubMed  Google Scholar 

  22. Archer JS, Chang RJ (2004) Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:737–754

    Article  PubMed  Google Scholar 

  23. Schüring AN, Kiesel L (2005) Hormonelle Therapie des polyzystischen Ovarsyndroms (PLOS). Gynäkologe 38:333–341

    Article  Google Scholar 

  24. Graf M (2006) CME Praktische Fortbildung—Gynäkologie, Geburtsmedizin und Gynäkologische Endokrinologie, akademos Wissenschaftsverlag, Hamburg, Germany 3

  25. Dahlgren E, Landin K, Krotkiewski M, Holm G, Janson PO (1998) Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 13:2706–2711

    PubMed  CAS  Google Scholar 

  26. Azziz R (2003) The evaluation and management of hirsutism. Obstet Gynecol 101:995–1007

    Article  PubMed  Google Scholar 

  27. Palombo-Kinne E, Schellschmidt I, Schumacher U, Graser T (2009) Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate. Contraception 79:282–289

    Article  PubMed  CAS  Google Scholar 

  28. Saleh AM, Khalil HS (2004) Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 83:614–621

    PubMed  Google Scholar 

  29. Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynecol 18(5):773–788

    Article  Google Scholar 

  30. Al-Azemi M, Omu FE, Omu AE (2004) The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 270:205–210

    Article  PubMed  Google Scholar 

  31. Clark AM, Ledger W, Galletly C et al (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705–2712

    PubMed  CAS  Google Scholar 

  32. Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G (2003) Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18:1928–1932

    Article  PubMed  Google Scholar 

  33. Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:773–788

    Article  PubMed  Google Scholar 

  34. Muth S, Norman J, Sattar N, Fleming R (2004) Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Hum Reprod 19:2718–2720

    Article  PubMed  CAS  Google Scholar 

  35. Kelly CJ, Gordon D (2002) The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol 147:217–221

    Article  PubMed  CAS  Google Scholar 

  36. Hahn S, Quadbeck B, Elsenbruch S et al (2004) Metformin, an efficacious drug in the treatment of polycystic ovary syndrome. Dtsch Med Wochenschr 129:1059–1064

    Article  PubMed  CAS  Google Scholar 

  37. Harborne L, Fleming R, Lyall H, Sattar N, Norman J (2003) Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 88:4116–4123

    Article  PubMed  CAS  Google Scholar 

  38. Lam PM, Cheung LP, Haines C (2004) Revisit of metformin treatment in polycystic ovarian syndrome. Gynecol Endocrinol 19:33–39

    Article  PubMed  CAS  Google Scholar 

  39. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2010) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev (1). Report. doi:10.1002/14651858.CD003053.pub4

  40. Bühling KJ, Bartley J, Lübbert H (2006) Einsatz oraler Antidiabetika in der Therapie des Kinderwunsches, des Gestationsdiabetes und zur Prävention des Typ-2- Diabetes. Geb Fra 66:1–5

    Google Scholar 

  41. De Leo V, la Marca A, Ditto A, Morgante G, Cianci A (1999) Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72:282–285

    Article  PubMed  Google Scholar 

  42. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876–1880

    Article  PubMed  CAS  Google Scholar 

  43. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ (2002) Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77:209–215

    Article  PubMed  Google Scholar 

  44. Palomba S, Orio F Jr, Falbo A et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068–4074

    Article  PubMed  CAS  Google Scholar 

  45. Tan SL, Farhi J, Homburg R, Jacobs HS (1996) Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH. Obstet Gynecol 88:221–226

    Article  PubMed  CAS  Google Scholar 

  46. Li TC, Saravelos H, Chow MS, Chisabingo R, Cooke ID (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 105:338–344

    Article  PubMed  CAS  Google Scholar 

  47. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83:2361–2365

    Article  PubMed  CAS  Google Scholar 

  48. Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P (2005) Laparoscopic “drilling” by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev CD001122

  49. Verhelst J, Gerris J, Joostens M, Van der Meer S, Van Royen E, Mahler C (1993) Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease. Gynecol Endocrinol 7:49–55

    Article  PubMed  CAS  Google Scholar 

  50. Farhi J, Soule S, Jacobs HS (1995) Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 64:930–935

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

ID, RD and KJB declare that they have no conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kai J. Buhling.

Appendix

Appendix

figure a

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doll, I., Doll, R. & Buhling, K.J. Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature. Arch Gynecol Obstet 285, 689–697 (2012). https://doi.org/10.1007/s00404-011-2014-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-2014-7

Keywords

Navigation